Loss of CD3 and TCRγδ expression in a relapsed hepatosplenic T-cell lymphoma

MeSH terms

• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• Biomarkers
• Biopsy
• CD3 Complex / genetics
• CD3 Complex / metabolism*
• Cyclophosphamide / therapeutic use
• Doxorubicin / therapeutic use
• Gene Expression
• Humans
• Immunohistochemistry
• Immunophenotyping
• Liver Neoplasms / diagnosis*
• Liver Neoplasms / drug therapy
• Liver Neoplasms / genetics
• Liver Neoplasms / metabolism*
• Lymphoma, T-Cell, Peripheral / diagnosis*
• Lymphoma, T-Cell, Peripheral / drug therapy
• Lymphoma, T-Cell, Peripheral / genetics
• Lymphoma, T-Cell, Peripheral / metabolism*
• Middle Aged
• Prednisone / therapeutic use
• Receptors, Antigen, T-Cell, gamma-delta / genetics
• Receptors, Antigen, T-Cell, gamma-delta / metabolism*
• Recurrence
• Splenic Neoplasms / diagnosis*
• Splenic Neoplasms / drug therapy
• Splenic Neoplasms / genetics
• Splenic Neoplasms / metabolism*
• Tomography, X-Ray Computed
• Vincristine / therapeutic use